Comparable antibody levels in heterologous and homologous mRNA COVID-19 vaccination, with superior neutralizing and IgA antibody responses in mRNA homologous boosting
<h3>Background </h3><p dir="ltr">Priming with two doses of AZD1222 (Oxford-AstraZeneca; ChAd) followed by a third mRNA vaccine boosting is considered in several countries, yet comparisons between heterologous and homologous booster efficacy remain unexplored. </p>&l...
Saved in:
| Main Author: | Salma Younes (6424865) (author) |
|---|---|
| Other Authors: | Eleonora Nicolai (496034) (author), Nadin Younes (4863280) (author), Massimo Pieri (5023022) (author), Sergio Bernardini (504056) (author), Parveen B. Nizamuddin (14590613) (author), Duaa W. Al-Sadeq (10976754) (author), Hanin I. Daas (17863886) (author), Ahmed Ismail (2671822) (author), Hadi M. Yassine (4675846) (author), Laith J. Abu-Raddad (9262524) (author), Gheyath K. Nasrallah (9200525) (author) |
| Published: |
2024
|
| Subjects: | |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Comparable antibody levels in heterologous and homologous mRNA COVID-19 vaccination, with superior neutralizing and IgA antibody responses in mRNA homologous boosting
by: Salma, Younes
Published: (2024) -
Thrombosis post-mRNA-based SARS-CoV-2 vaccination (BNT162b2) – Time to think beyond thrombosis with thrombocytopenia syndrome (TTS)
by: Zohaib Yousaf (9617058)
Published: (2022) -
Follow‐Up and Comparative Assessment of SARS‐CoV‐2 IgA, IgG, Neutralizing, and Total Antibody Responses After BNT162b2 or mRNA‐1273 Heterologous Booster Vaccination
by: Salma Younes (6424865)
Published: (2024) -
Lack of F8 mRNA
by: El Maarri, Osman
Published: (2006) -
Follow up and comparative assessment of IgG, IgA, and neutralizing antibody responses to SARS-CoV-2 between mRNA-vaccinated naïve and unvaccinated naturally infected individuals over 10 months
by: Salma, Younes
Published: (2023)